Regional infusion of a class C TLR9 agonist enhances liver tumor microenvironment reprogramming and MDSC reduction to improve responsiveness to systemic checkpoint inhibition
暂无分享,去创建一个
S. Katz | B. Cox | P. Guha | D. Greer | C. Ghosh | J. Laporte | Kara R. Heatherton | I. S. Alexander | Kyle P O' Connell | Prajna Guha | K. O. ’. Connell